Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro
about
HIV-1 gene expression: lessons from provirus and non-integrated DNAResidual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsDual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissueSAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cellsHIV restriction in quiescent CD4⁺ T cellsHuman immunodeficiency virus (HIV)-1 integration sites in viral latencyInhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitorsCNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsNuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors.Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cellsPreferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factorsA novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cellsExpression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cellsDifferential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level.Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase.Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitorsModalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytesPersistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.COP9 signalosome component JAB1/CSN5 is necessary for T cell signaling through LFA-1 and HIV-1 replication.Reduced cellular susceptibility to in vitro HIV infection is associated with CD4+ T cell quiescence.Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivoA primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescenceSulfonation pathway inhibitors block reactivation of latent HIV-1.Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells.HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes.Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.Highly purified CD25- resting T cells cannot be infected de novo with HIV-1Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes.Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1.
P2860
Q21245215-E0F0EA57-75EA-459B-BCB7-A6083C98249EQ24548940-BE819BC4-6443-420A-8E46-6BE787C4F39DQ24562082-448ADD25-8DD1-47A8-A947-76DD44FBE698Q24615124-0809D7D6-AC40-497F-99E7-2CA65C150847Q26995784-AB50304A-8BFD-4DCD-95B5-0400D94E7EC3Q27026246-DC5534D6-988E-40AE-A7CA-5002AD8C60B9Q28344365-821B6359-9BF1-48E8-AEB6-92FBAC6175D9Q28379514-1384C9EE-52CD-4D52-90CC-6D6F78CAD2B9Q28538015-A2061ABB-0A06-4A17-B031-CFD7E9C4AC7FQ33250088-8F07B39D-AE12-4259-A352-C7F3600AC69BQ33367106-4A35E74A-FDD5-4412-9B0B-3F4D464D1533Q33404066-BA6064C3-BC76-4200-9AF4-2EF3E4AABBD9Q33511958-98F7C3F2-623F-4CE9-9C6F-CDC471734AE2Q33724212-9CEE88DC-17FB-4BE6-BF30-DA6D465D092FQ33724247-855D55D1-D546-4202-A438-AA26C1FB2FE4Q33782776-772F03CE-E7A3-47AB-B022-70CF7BF8123AQ33784182-C9FA43FA-62A5-4469-8A5F-283E3A64EAC4Q33785609-9A1773BF-599E-45A4-8C5E-AECB59C558CCQ33785876-F7B00EAE-D429-4C59-9202-B06F8A9A5045Q33814773-595D5896-E197-4C12-8C18-FB305DC8F2FDQ33888794-8D045522-3F4F-49E9-B98C-3ED8D1DA7458Q34124009-A6F2A9F4-C1D1-4672-8DF1-D2139BF72EC6Q34301688-9CB42538-E1A3-4283-910E-156EABF2B921Q34344987-132FB74A-7346-456F-B7F4-46A82FF34FF3Q34345655-9628BD79-DF43-4815-88E2-EB296032EA8EQ34388158-FE42B346-A95D-49B9-8B12-C639AE951E41Q34430345-555ED8F2-2F5F-4344-A283-785A6C6EAFF9Q35149006-DDA005B1-6B84-4C9E-BA1D-E048EAF2FEBDQ35229849-D20E411B-C050-4270-B301-1DFAD0874074Q35358497-9EC53676-D62C-4646-A037-F3E40B04EB2CQ35382357-CD28F402-17DB-4863-B210-00A2EB00C93CQ35661660-0CB23AD1-EFB3-4C65-9DFA-84E2157C78BCQ35785154-D4BEEB8C-F0D6-45F1-B6D9-429FD39CCE68Q35859899-CCD6DFA3-D59A-47A0-BDBA-F680B3CD9A98Q35861719-B1C791F3-CCFF-4E7C-8585-8790EF3FE1DEQ35918353-6FA63542-BA42-469A-900E-D54853774441Q35996665-9FC3D498-8672-4224-83AC-D74D1A684F00Q36063873-F167DE17-01D7-432D-816D-E4447497F166Q36102514-80B9B1CB-C86D-45C9-BBAF-86C0FE384E38Q36217786-E190B2D2-6BB6-4614-A51B-627728E07DDE
P2860
Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Establishment of a stable, ind ...... scent CD4 lymphocytes in vitro
@ast
Establishment of a stable, ind ...... scent CD4 lymphocytes in vitro
@en
type
label
Establishment of a stable, ind ...... scent CD4 lymphocytes in vitro
@ast
Establishment of a stable, ind ...... scent CD4 lymphocytes in vitro
@en
prefLabel
Establishment of a stable, ind ...... scent CD4 lymphocytes in vitro
@ast
Establishment of a stable, ind ...... scent CD4 lymphocytes in vitro
@en
P2093
P2860
P1433
P1476
Establishment of a stable, ind ...... scent CD4 lymphocytes in vitro
@en
P2093
D D Richman
J C Guatelli
P2860
P304
P407
P577
1995-05-01T00:00:00Z